Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7709486 CXCR4 antagonists

Patent 7709486 was granted and assigned to Genzyme on May, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

David Earl Bogucki0

Dominique Schols0

Eva Maria Boehringer0

Gary J. Bridger0

Renato Tony Skerlj0

Zhongren Wang0

Date of Patent

May 4, 2010

0

Patent Application Number

121820440

Date Filed

July 29, 2008

0

Patent Citations Received

US Patent 11987598 E-selectin antagonist compounds, compositions, and methods of use

0

US Patent 11707474 Methods for treating acute myeloid leukemia and related conditions

0

US Patent 11712446 Methods of mobilizing marrow infiltrating lymphocytes and uses thereof

0

US Patent 11780873 Highly potent multimeric e-selectin antagonists

US Patent 11878026 Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists

0

Patent Primary Examiner

Brenda L Coleman

0

Patent abstract

The present invention is drawn to novel antiviral compounds, pharmaceutical compositions and their use. More specifically this invention is drawn to derivatives of monocyclic polyamines which have activity in standard tests against HIV- or FIV-infected cells as well as other biological activity related to binding of ligands to chemokine receptors that mediate a number of mammalian embryonic developmental processes.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7709486 CXCR4 antagonists

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool